 |
Medication Safety Officers Society 3673 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations |
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
How do you manage sickle cell patients on long acting opioids when a provider wants to start PCA? We have a provider advocating that the patients stay on their long acting opioid and add PCA without a basal rate to use for breakthrough pain. She feels this is safer than stopping home opioids and trying to convert to IV with a basal rate.
Our current policy says no additional opioids with PCA so she wants an exception made for these patients.
Thank you!
Carol